Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
ABC's Amy Robach to Have Breast Cancer Surgery
ABC correspondent Amy Robach said Monday that she has breast cancer and will undergo a double mastectomy and reconstructive surgery this week.
Her announcement comes a month after she underwent a mammogram for a story on "Good Morning America." The 40-year-old mother of two was chosen for the assignment because she's at an age when it's recommended that women regularly check for breast cancer, the Associated Press reported.
A few weeks after the mammogram, Robach learned she had breast cancer. Following Thursday's surgery, she will find out what further treatment she may require.
Robach said she was initially reluctant to have the public mammogram, but decided to do it after "Good Morning America" anchor Robin Roberts said it would be worth it if the story saved one life, AP reported.
"It never occurred to me that life would be mine," Robach said.
Prepared Sandwiches, Salads Recalled by California Caterer
A California catering company is recalling more than 90 tons of ready-to-eat sandwiches and salads after 26 people in three states were sickened by E. coli, the USDA's Food and Safety Inspection Service says.
Glass Onion Catering is recalling nearly 182,000 pounds of salads and sandwich wraps that contain cooked chicken and ham. They were produced between Sept. 23 and Nov. 6 and sent to distribution centers in Arizona, California, Nevada, New Mexico, Oregon, Utah, Washington and Texas, the Associated Press reported.
The company supplies food to Trader Joe's, Super Fresh Goods and Delish, according to the Contra Costa Times.
A full list of the recalled products is available on the Food and Drug Administration website, the AP reported.
Meningitis Outbreak Declared at Princeton University
New Jersey health officials have declared a meningitis outbreak on the Princeton University campus, where there have been six confirmed and one suspected case of the disease since March.
The possible case involves a male student who developed symptoms on Saturday and is in hospital. Five of the six confirmed cases involved students and all the patients have recovered, the Associated Press reported.
The outbreak was declared in an effort to raise awareness on the campus, according to state health officials.
They said meningitis can be spread through kissing, coughing or lengthy contact. Symptoms include headache, fever, vomiting and rashes, the AP reported.
Weight Loss Products Recalled After Liver Illnesses
A number of OxyElite Pro weight loss supplements are being recalled after being linked to an outbreak of liver illnesses, including one death, the U.S. Food and Drug Administrations says.
The recalled products include certain packages of OxyElite Pro Super Thermo capsules, OxyElite Pro Ultra-Intense Thermo capsules and OxyElite Super Thermo Powder, USA Today reported.
The products are made by USPlabs of Dallas. Last month, the FDA told the company that it considered OxyElite Pro and another of the company's supplements, VERSA-1, to be adulterated because they include a new dietary supplement ingredient called aegeline.
The FDA said there is a lack of evidence about the safety of aegeline, a compound found in an Asian tree. USPlabs disputed the FDA's position.
Last week, the FDA told USPlabs that if it did not voluntarily recall the OxyElite Pro products with aegeline, the agency would order the company to stop distribution of the products immediately and tell other distributors and retailers to stop selling them, USA Today reported.
Copyright © 2014 HealthDay. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit Health News on healthfinder.gov.
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.